COVID-19 transmission
Cheryl Guttman Krader
Published: Sunday, May 10, 2020
[caption id="attachment_18617" align="alignnone" width="600"]
Image by Vektor Kunst from Pixabay[/caption]
Authors of a recent study determined that COVID-19 might be most transmissible before infected individuals even develop symptoms.
Conducted by Xi He MD, Guangzhou Medical University, Guangzhou, China, and colleagues, the research was published online in the journal Nature Medicine on April 15, 2020.
https://www.medrxiv.org/content/10.1101/2020.04.09.20058941v1
Based on their findings, Xe et al recommended that strategies for controlling the spread of COVID-19 should be adjusted to account for probable substantial presymptomatic transmission. Noting that the effectiveness of measures that are instituted when individuals become symptomatic are reduced in the setting of significant presymptomatic transmission, they urged consideration be given to developing more inclusive criteria for contact tracing to capture transmission events two-to-three days before symptom onset
Commenting on the report, Anthony L. Komaroff, MD, Founding Editor, NEJM Journal Watch General Medicine, also observed that the findings suggest aggressive contact tracing will be critical for controlling spread of COVID-19 whereas quarantining will be less effective than it was for containing SARS, a disease for which peak infectiousness occurs seven-to-10 days after symptom onset.
The Chinese researchers used data from two patient cohorts to investigate when during the course of COVID-19 the causative viral pathogen is most transmissible. First they analysed viral loads on a total of 414 throat swabs obtained from 94 patients with laboratory-confirmed COVID-19. All of the patients had been hospitalised and were classified as being moderately ill. The swabs were first obtained at the time of symptom onset and for a period ranging up to 32 days.
The results showed that viral loads on the swabs were highest for specimens collected soon after symptom onset, decreased rapidly over the next seven days and then fell towards the detection limit after about 21 days.
For the second part of their study, the researchers calculated the serial interval (time between symptom onset of successive cases in a transmission chain) using data from 77 pairs of index and secondary cases. They found the mean serial interval between the cases in the transmission pairs was 5.8 days and the median was 5.2 days.
Assuming the incubation period averages 5.2 days, they determined that infectiousness begins 2.3 days before symptom onset and reaches its peak at 0.7 days before symptom onset. According to their modeling, Xe et al determined that in settings where transmission occurred among household contacts, 44% of secondary cases became infected during a period when the index case was still asymptomatic. The authors cited a previous study reporting even higher presymptomatic transmission rates of 48% and 62%.
Image by Vektor Kunst from Pixabay[/caption]
Authors of a recent study determined that COVID-19 might be most transmissible before infected individuals even develop symptoms.
Conducted by Xi He MD, Guangzhou Medical University, Guangzhou, China, and colleagues, the research was published online in the journal Nature Medicine on April 15, 2020.
https://www.medrxiv.org/content/10.1101/2020.04.09.20058941v1
Based on their findings, Xe et al recommended that strategies for controlling the spread of COVID-19 should be adjusted to account for probable substantial presymptomatic transmission. Noting that the effectiveness of measures that are instituted when individuals become symptomatic are reduced in the setting of significant presymptomatic transmission, they urged consideration be given to developing more inclusive criteria for contact tracing to capture transmission events two-to-three days before symptom onset
Commenting on the report, Anthony L. Komaroff, MD, Founding Editor, NEJM Journal Watch General Medicine, also observed that the findings suggest aggressive contact tracing will be critical for controlling spread of COVID-19 whereas quarantining will be less effective than it was for containing SARS, a disease for which peak infectiousness occurs seven-to-10 days after symptom onset.
The Chinese researchers used data from two patient cohorts to investigate when during the course of COVID-19 the causative viral pathogen is most transmissible. First they analysed viral loads on a total of 414 throat swabs obtained from 94 patients with laboratory-confirmed COVID-19. All of the patients had been hospitalised and were classified as being moderately ill. The swabs were first obtained at the time of symptom onset and for a period ranging up to 32 days.
The results showed that viral loads on the swabs were highest for specimens collected soon after symptom onset, decreased rapidly over the next seven days and then fell towards the detection limit after about 21 days.
For the second part of their study, the researchers calculated the serial interval (time between symptom onset of successive cases in a transmission chain) using data from 77 pairs of index and secondary cases. They found the mean serial interval between the cases in the transmission pairs was 5.8 days and the median was 5.2 days.
Assuming the incubation period averages 5.2 days, they determined that infectiousness begins 2.3 days before symptom onset and reaches its peak at 0.7 days before symptom onset. According to their modeling, Xe et al determined that in settings where transmission occurred among household contacts, 44% of secondary cases became infected during a period when the index case was still asymptomatic. The authors cited a previous study reporting even higher presymptomatic transmission rates of 48% and 62%.
Tags: covid-19 research
Latest Articles
ESCRS Today 2025: Happy Anniversaries!
ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.
ESCRS Today 2025: A Congress for Everyone
From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.
Beyond the Numbers
Empowering patient participation fosters continuous innovation in cataract surgery.
Thinking Beyond the Surgery Room
Practice management workshop focuses on financial operations and AI business applications.
Aid Cuts Threaten Global Eye Care Progress
USAID closure leads retreat in development assistance.
Supplement: ESCRS Clinical Trends Series: Presbyopia
Debate: FS-LASIK or KLEx for Hyperopia?
FS-LASIK has more of a track record, but KLEx offers advantages.
Four AI Applications Ready for Practice
Commercial offerings may save time, improve practice and research.
Perioperative Medication Regimens for Cataract Surgery
Randomised controlled clinical trial results provide evidence-based guidance.